157 results on '"Räuber, Saskia"'
Search Results
2. Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort
3. [18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis
4. Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis
5. Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell–mediated limbic encephalitis
6. Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
7. Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering
8. Classification of neurological diseases using multi-dimensional cerebrospinal fluid analysis
9. sCD14, a marker of immune-inflammation can help to distinguish between psychotic disorders with and without disordered social interaction
10. Social interaction, psychotic disorders and inflammation: A triangle of interest
11. Author response: Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia
12. Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia
13. Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
14. Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses
15. Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells
16. Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice
17. The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome
18. [18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis.
19. The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis
20. Anti-N-Methyl-D-Aspartat-Enzephalitis in der Epileptologie
21. Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia
22. Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls
23. Recombinant acetylcholine receptor immunization induces a robust model of experimental autoimmune myasthenia gravis in mice
24. Eculizumab treatment alters the proteometabolome beyond the inhibiton of complement
25. Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis (P5-5.016)
26. Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab
27. Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis
28. Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis
29. Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany
30. Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab
31. sj-docx-1-dhj-10.1177_20552076231152989 - Supplemental material for Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany
32. High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
33. Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus Vaccination
34. Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies
35. Modulation of Rxrα Expression in Mononuclear Phagocytes Impacts on Cardiac Remodeling after Ischemia-Reperfusion Injury
36. A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab
37. Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab
38. Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort
39. Additional file 2 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
40. Additional file 3 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
41. Additional file 7 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
42. Additional file 1 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
43. Additional file 6 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
44. Additional file 5 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
45. Additional file 4 of Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
46. Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis
47. Impact of T cells on neurodegeneration in anti‐GAD65 limbic encephalitis
48. NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection
49. Einfluss des Retinoid-X-Rezeptors α in Monozyten und Makrophagen auf die Umbau- und Heilungsprozesse nach akutem Myokardinfarkt
50. Classification of neurological diseases using multi-dimensional CSF analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.